Showing results (131-140 of 367) with videos related to
Sort By:
Pageof 37
The American Journal of Cardiology|August 9, 2006
Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries)Amit Segev, Bradley H Strauss, Mary Tan, et al.The Canadian Journal of Cardiology|February 18, 2006
Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromesAndrew T Yan, Raymond T Yan, Mary Tan, et al.European Heart Journal|December 22, 2012
Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpointJeffrey A Bakal, Cynthia M Westerhout, Warren J Cantor, et al.Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|May 17, 2015
Use of Cardiac Magnetic Resonance Imaging Based Measurements of Inferior Vena Cava Cross-Sectional Area in the Diagnosis of Pericardial ConstrictionKate Hanneman, Paaladinesh Thavendiranathan, Elsie T Nguyen, et al.American Journal of Respiratory and Critical Care Medicine|June 15, 2018
Abrupt Deflation after Sustained Inflation Causes Lung InjuryBhushan H Katira, Doreen Engelberts, Gail Otulakowski, et al.The Journal of Pediatrics|December 3, 2016
Left Ventricular Function in Healthy Term Neonates During the Transitional PeriodAmish Jain, Afif F El-Khuffash, Bart C W Kuipers, et al.Journal of Magnetic Resonance Imaging : JMRI|May 31, 2013
Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosisYuesong Yang, Katherine Safka, John J Graham, et al.The Canadian Journal of Cardiology|August 12, 2022
The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysisMuhammad Usman Ali, G B John Mancini, Donna Fitzpatrick-Lewis, et al.Acta Diabetologica|June 14, 2014
Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studiesKim A Connelly, Andrew Advani, Suzanne L Advani, et al.Diabetes, Obesity & Metabolism|March 3, 2020
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?Ruth L Coleman, Alastair M Gray, Uli C Broedl Md, et al.Pageof 37